Invesco’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.8M Buy
4,450,066
+1,342,413
+43% +$21.4M 0.01% 996
2025
Q4
$50.5M Buy
3,107,653
+2,216,595
+249% +$36.2M ﹤0.01% 1080
2025
Q3
$13.3M Sell
891,058
-17,356
-2% -$211K ﹤0.01% 1655
2025
Q2
$10.6M Buy
908,414
+355,883
+64% +$3.23M ﹤0.01% 1741
2025
Q1
$4.11M Buy
552,531
+378,940
+218% +$2.91M ﹤0.01% 2254
2024
Q4
$1.04M Buy
173,591
+4,985
+3% +$27.5K ﹤0.01% 2904
2024
Q3
$863K Sell
168,606
-3,254
-2% -$14.2K ﹤0.01% 2975
2024
Q2
$622K Sell
171,860
-2,696
-2% -$8.56K ﹤0.01% 3182
2024
Q1
$560K Buy
174,556
+66,015
+61% +$255K ﹤0.01% 3272
2023
Q4
$532K Buy
108,541
+1,215
+1% +$5.54K ﹤0.01% 3179
2023
Q3
$585K Sell
107,326
-2,860
-3% -$18.9K ﹤0.01% 3126
2023
Q2
$739K Buy
110,186
+3,775
+4% +$28.1K ﹤0.01% 3036
2023
Q1
$940K Buy
106,411
+12,316
+13% +$109K ﹤0.01% 2928
2022
Q4
$719K Buy
94,095
+2,380
+3% +$18.5K ﹤0.01% 3096
2022
Q3
$653K Sell
91,715
-2,780
-3% -$26.2K ﹤0.01% 3108
2022
Q2
$764K Sell
94,495
-51,305
-35% -$451K ﹤0.01% 3112
2022
Q1
$2.02M Sell
145,800
-1,403,282
-91% -$22.1M ﹤0.01% 2783
2021
Q4
$43.5M Buy
1,549,082
+36,538
+2% +$1.12M 0.01% 1108
2021
Q3
$51.4M Sell
1,512,544
-20,090
-1% -$727K 0.01% 1038
2021
Q2
$62.6M Buy
1,532,634
+213,167
+16% +$8.29M 0.02% 990
2021
Q1
$53.1M Sell
1,319,467
-204,963
-13% -$11.1M 0.01% 1035
2020
Q4
$90.1M Buy
1,524,430
+254,801
+20% +$13.1M 0.03% 779
2020
Q3
$61.7M Buy
1,269,629
+38,792
+3% +$1.63M 0.02% 843
2020
Q2
$59.5M Buy
1,230,837
+1,006,018
+447% +$36.7M 0.02% 823
2020
Q1
$6.25M Sell
224,819
-30,549
-12% -$852K ﹤0.01% 1765
2019
Q4
$7.64M Buy
255,368
+25,614
+11% +$736K ﹤0.01% 1917
2019
Q3
$7.1M Buy
229,754
+4,754
+2% +$194K ﹤0.01% 1922
2019
Q2
$10.9M Buy
+225,000
New +$9.97M ﹤0.01% 1708

Other funds holding ADPT